Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.140
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST - Market closed
ZYBT Revenue
Zhengye Biotechnology Holding had revenue of 62.33M CNY in the half year ending June 30, 2025, a decrease of -46.66%. This brings the company's revenue in the last twelve months to 153.74M, down -18.98% year-over-year. In the year 2024, Zhengye Biotechnology Holding had annual revenue of 186.36M, down -11.95%.
Revenue (ttm)
153.74M CNY
Revenue Growth
-18.98%
P/S Ratio
2.47
Revenue / Employee
555,000 CNY
Employees
277
Market Cap
54.03M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 186.36M | -25.30M | -11.95% |
| Dec 31, 2023 | 211.65M | -48.62M | -18.68% |
| Dec 31, 2022 | 260.27M | 46.20M | 21.58% |
| Dec 31, 2021 | 214.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionZYBT News
- 6 months ago - Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results - PRNewsWire
- 8 months ago - Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 1 year ago - U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline - Seeking Alpha
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewsWire
- 2 years ago - Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO - Seeking Alpha